packageFedratinib

fedratinib

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Fedratinib is a JAK inhibitor used to treat myelofibrosis. It is authorised in the European Union for myeloproliferative disorders, including primary myelofibrosis.

Summary written by glm-5.3-flash from Wikidata Q7670147 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:fedratinib
ATC codes:L01EJ02
DrugBank:DB12500
PubChem CID:16722836
ChEBI:91408
Wikidata:Q7670147
formula:C27H36N6O3S
molar mass:524.684 g/mol (PubChem CID 16722836)
logP:4.8 (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown